Latest Breaking News On - Vishal maheshwari - Page 1 : vimarsana.com

KKR acquires minority stake in healthcare revenue solutions provider Infinix Services

Mumbai-based Infinx provides provides data-driven, AI-led revenue cycle management systems focused on the US market in the healthcare domain.

Vishal maheshwariSandeep tandonB asia pacificJaideep tandonManish bafnaHealthium groupApax partnersInfinx servicesAsian fundMumbai based infinx servicesVenture partnersManaging directorNorwest indiaAsia pacific infrastructure investors

KKR buys Healthium Medtech from Apax Funds

KKR buys Healthium Medtech from Apax Funds
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Vishal maheshwariHealthium medtechManish bafnaAsia pacificAsian fundApax partnersBengaluru based healthium medtechApax funds

KKR to Acquire Healthium from Apax Funds

KKR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd. , a leading Indian medical devices.

Manish bafnaBushu pharmaVishal maheshwariAsia pacificSteven dysonSimpson thacher bartlettAsian fundHealthium medtech ltdApax partnersKirkland ellisGlobal atlantic financial groupMoelis companyHealthium medtechApax fundsIndia private equityChief executive officer

KKR to buy Healthium from Apax Partners - The Hindu BusinessLine

KKR to buy Healthium from Apax Partners - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Healthium medtechVishal maheshwariAsia pacificManish bafnaLord mark industriesAsian fundApax partnersApax fundsOmark industriesAkshay tannaIndia private equity

KKR to buy Indian medical devices firm Healthium Medtech from Apax

Bloomberg, citing sources, reported the transaction could be valued at as much as $1 billion.

United statesMaiva pharmaVishal maheshwariManish bafnaHealthium medtechAsian fundIndia life sciences fundApax fundsAkshay tannaIndia private equityMax healthcareGland pharmaManipal hospitalsNorth americaMorgan stanley private equity asia